M30.0 - Polyarteritis nodosa
ICD-10: | M30.0 |
Short Description: | Polyarteritis nodosa |
Long Description: | Polyarteritis nodosa |
Status: | Valid for Submission |
Version: | ICD-10-CM 2023 |
Code Classification: |
M30.0 is a billable ICD-10 code used to specify a medical diagnosis of polyarteritis nodosa. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Benign cutaneous periarteritis nodosa
- Cutaneous polyarteritis nodosa
- Myopathy due to polyarteritis nodosa
- Nephrotic syndrome in polyarteritis nodosa
- Periarteritis
- Polyarteritis
- Polyarteritis nodosa
- Polyarteritis nodosa with multi-organ involvement
- Polyarteritis nodosa with single organ involvement
- Polyneuropathy in collagen vascular disease
- Polyneuropathy in polyarteritis nodosa
- Primary systemic arteritis
- Retinal vasculitis due to polyarteritis nodosa
- Vasculitis of medium sized vessel
Clinical Information
- Polyarteritis Nodosa-. a form of necrotizing non-granulomatous inflammation occurring primarily in medium-sized arteries, often with microaneurysms. it is characterized by muscle, joint, and abdominal pain resulting from arterial infarction and scarring in affected organs. polyarteritis nodosa with lung involvement is called churg-strauss syndrome.
Index to Diseases and Injuries References
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for this diagnosis code are found in the injuries and diseases index:
- - Dementia (degenerative (primary)) (old age) (persisting) (unspecified severity) (without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety) - F03.90
- - in (due to)
- - polyarteritis nodosa - See Also: Dementia, in, diseases specified elsewhere; - M30.0
- - with behavioral disturbance - See Also: Dementia, in, diseases specified elsewhere; - M30.0
- - polyarteritis nodosa - See Also: Dementia, in, diseases specified elsewhere; - M30.0
- - in (due to)
- - Kussmaul's
- - disease - M30.0
- - Myopathy - G72.9
- - in (due to)
- - polyarteritis nodosa - M30.0
- - in (due to)
- - Panangiitis - M30.0
- - Panarteritis nodosa - M30.0
- - Polyangiitis - M30.0
- - Polyarteritis
- - nodosa - M30.0
- - Polyneuropathy (peripheral) - G62.9
- - in (due to)
- - polyarteritis nodosa - M30.0
- - in (due to)
Convert to ICD-9 Code
Source ICD-10 Code | Target ICD-9 Code | |
---|---|---|
M30.0 | 446.0 - Polyarteritis nodosa | |
Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code. |
Patient Education
Vasculitis
Vasculitis is an inflammation of the blood vessels. It happens when the body's immune system attacks the blood vessel by mistake. It can happen because of an infection, a medicine, or another disease. The cause is often unknown.
Vasculitis can affect arteries, veins and capillaries. Arteries are vessels that carry blood from the heart to the body's organs. Veins are the vessels that carry blood back to the heart. Capillaries are tiny blood vessels that connect the small arteries and veins.
When a blood vessel becomes inflamed, it can:
- Narrow, making it more difficult for blood to get through
- Close off completely so that blood can't get through
- Stretch and weaken so much that it bulges. The bulge is called an aneurysm. If it bursts, it can cause dangerous bleeding inside the body.
Symptoms of vasculitis can vary, but usually include fever, swelling and a general sense of feeling ill. The main goal of treatment is to stop the inflammation. Steroids and other medicines to stop inflammation are often helpful.
NIH: National Heart, Lung, and Blood Institute
[Learn More in MedlinePlus]
Adenosine deaminase 2 deficiency
Adenosine deaminase 2 (ADA2) deficiency is a disorder characterized by abnormal inflammation of various tissues. Signs and symptoms can begin anytime from early childhood to adulthood. The severity of the disorder also varies, even among affected individuals in the same family.
Inflammation is a normal immune system response to injury and foreign invaders (such as bacteria). However, ADA2 deficiency causes abnormal, unprovoked inflammation that can damage the body's tissues and organs, particularly blood vessels. (Inflammation of blood vessels is known as vasculitis.) Other tissues affected by abnormal inflammation can include the skin, gastrointestinal system, liver, kidneys, and nervous system. Depending on the severity and location of the inflammation, the disorder can cause disability or be life-threatening.
Signs and symptoms that can occur with ADA2 deficiency include fevers that are intermittent, meaning they come and go; areas of net-like, mottled skin discoloration called livedo racemosa; an enlarged liver and spleen (hepatosplenomegaly); and recurrent strokes affecting structures deep in the brain that can start in the first few years of life. In some people, ADA2 deficiency causes additional immune system abnormalities that increase the risk of bacterial and viral infections.
ADA2 deficiency is sometimes described as a form of polyarteritis nodosa (PAN), a disorder that causes inflammation of blood vessels throughout the body (systemic vasculitis). However, not all researchers classify ADA2 deficiency as a type of PAN.
[Learn More in MedlinePlus]
Code History
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)